Mapfre (MAP) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
18 May, 2026Opening remarks and agenda
The meeting was held both in-person and via telematic means, with live internet broadcast and high shareholder participation, reaching 84.93% attendance.
The agenda included approval of annual accounts, management reports, application of results, corporate governance, director elections, bylaw amendments, remuneration, treasury shares, dividend approval, and delegation of powers.
Financial performance review
Premiums reached EUR 29.1 billion (+3.8%), total revenues EUR 34.5 billion (+4%), and net profit exceeded EUR 1 billion for the first time, up 17% year-on-year.
Attributable equity rose to EUR 9.4 billion (+5.9%), ROE was 12.4% (13.3% excluding extraordinary items), and the solvency ratio stood at 210.4%.
Combined ratio improved to 92.2%, the best in the historical series, with strong technical results across all regions and lines.
Share price rose over 75% in 2025, with total shareholder return exceeding 80%.
Board and executive committee updates
Re-election of executive and independent directors, including the ratification of appointments and recognition of outgoing board members.
Board composition changes to ensure a majority of independent directors and term limits for external directors.
Latest events from Mapfre
- Strong financials, market leadership, and ambitious ESG targets drive resilient performance.MAP
Investor presentation21 May 2026 - Net profit up 12.7% to EUR 310.9 million, with strong technical and financial performance.MAP
Q1 2026 (Media)29 Apr 2026 - Net profit up 12.7% to €311 million, with improved combined ratios and strong financial income.MAP
Q1 202629 Apr 2026 - Net profit up 19.6% to €1.08B, record premiums, best-ever combined ratio, and largest dividend.MAP
Q4 202517 Feb 2026 - Net profit up 19.6% to €1.1B, record premiums, improved ratios, and record dividend payout.MAP
Q4 2025 (Media)12 Feb 2026 - Net result up 47% to €462 million, driven by premium growth and improved profitability.MAP
Q2 20242 Feb 2026 - Net result up 39% to EUR 654 million, premiums rose 4.6%, and dividend increased 8%.MAP
Q3 202418 Jan 2026 - Record net profit and historic dividend highlight a robust year and positive outlook.MAP
Q4 2024 TU8 Jan 2026 - Net profit surged 27.6% to €276 million, led by Non-Life and Auto technical improvements.MAP
Q1 202521 Dec 2025